OctreoPharm Sciences
Focused on the development of new radio pharmaceuticals for neuroendocrine tumors.
Enterprise value
$22—33m
Company register number
HRB 133718 B (Charlottenburg (Berlin))
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
€50.0m | Acquisition | ||
| Total Funding | 000k | ||
IBB Ventures(exited)
| EUR | 2010 | 2011 | 2012 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.